Abbott India Limited vs UPL Limited
Put two companies head-to-head — source-verified financials and AI-analysed SWOT, together in one view.
Abbott India Limited (Pharmaceuticals) and UPL Limited (Agrochemicals and agricultural solutions) go head-to-head here — with source-verified financials and a full SWOT breakdown side by side on Nexvora Intelligence. On the figures reported, UPL Limited leads on Revenue (approx.).
UPL Limited leads on Revenue (approx.).
Head-to-head highlights
| Metric | Abbott India Limited | UPL Limited | Basis |
|---|---|---|---|
| Revenue (approx.) | INR 5,800-6,200 crore | Approximately ₹40,000-45,000 crore, unverified rough range | AI estimate |
An arrow marks the larger reported figure — a factual comparison, not a quality judgement. Verified figures come from official filings; AI estimates are approximate and unverified.
Abbott India Limited
Pharmaceuticals · India
Abbott India Limited is an Indian pharmaceutical company and a listed subsidiary of Abbott Laboratories. It markets branded prescription and over-the-counter healthcare products across therapeutic areas such as gastroenterology, women's health, metabolic disorders, central nervous system, pain management, and vaccines.
Verified financials
No source-verified financials available.
Strengths
- Strong parentage from Abbott Laboratories
- Recognized brands in chronic and specialty therapeutic areas
- Established doctor and pharmacy distribution network
- Focus on higher-margin branded formulations
Weaknesses
- High dependence on the Indian domestic pharmaceutical market
- Limited scale compared with India's largest pharma companies
- Exposure to price controls on essential medicines
- Relatively concentrated portfolio in select therapies
Opportunities
- Growth in chronic disease treatment demand in India
- Expansion in women's health, gastroenterology, and metabolic care
- Digital engagement with physicians and patients
- Leveraging Abbott's global portfolio for India-specific launches
Threats
- Intense competition from Indian generic and branded-generic companies
- Regulatory pricing pressure from India's drug price control regime
- Changes in physician prescribing behavior
- Supply chain and input cost volatility
UPL Limited
Agrochemicals and agricultural solutions · India
UPL Limited is an Indian multinational agricultural solutions company focused on crop protection, seeds, biosolutions, and related farm inputs. It serves farmers, distributors, and agricultural businesses across global markets with a broad portfolio of off-patent and differentiated products.
Verified financials
No source-verified financials available.
Strengths
- Broad global crop protection portfolio
- Strong presence in emerging agricultural markets
- Large-scale manufacturing and formulation capabilities
- Established distribution reach across many countries
Weaknesses
- Exposure to cyclical agrochemical demand and channel destocking
- Significant debt burden following past expansion and acquisitions
- Margin pressure from pricing competition in generic crop protection
- Complex global regulatory and registration requirements
Opportunities
- Growth in biological and sustainable crop inputs
- Expansion of seed and differentiated product platforms
- Rising food security needs in emerging markets
- Digital and advisory services for farmers
Threats
- Volatile raw material and input costs
- Regulatory restrictions on certain agrochemical molecules
- Currency fluctuations across international markets
- Competition from Chinese and other low-cost generic producers
Frequently asked
Answered from source-verified figures on this page.
Abbott India Limited vs UPL Limited: which company leads overall?
UPL Limited leads on Revenue (approx.).
Related market reports
Deep-dive intelligence on the markets these companies compete in.
India Protein Industry Outlook — Intelligence Report
India Pharmaceutical Sector — Intelligence Report
Global Radiopharmaceuticals and Theranostics Market — Intelligence Report
India EV Charging Market — Entry Intelligence Report
AI Analyst
Insights and answers generated live from Abbott India Limited vs UPL Limited's verified data. Modeled estimates — not investment advice.
- Abbott India Limited is a listed Indian subsidiary of Abbott Laboratories operating in pharmaceuticals.
- Abbott India markets branded prescription and OTC healthcare products across gastroenterology, women’s health, metabolic disorders, central nervous system, pain management, and vaccines.
- UPL Limited is an Indian multinational focused on agrochemicals and agricultural solutions, including crop protection, seeds, biosolutions, and related farm inputs.
- UPL serves farmers, distributors, and agricultural businesses across global markets with a portfolio of off-patent and differentiated products.
- Notable point: the two companies operate in very different sectors, with Abbott India in healthcare and UPL in agriculture.